245 related articles for article (PubMed ID: 24577510)
21. Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB.
Joseph J; Mudduluru G; Antony S; Vashistha S; Ajitkumar P; Somasundaram K
Oncogene; 2004 Aug; 23(37):6304-15. PubMed ID: 15318170
[TBL] [Abstract][Full Text] [Related]
22. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
25. BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells.
Chen E; Pei R
J Int Med Res; 2020 May; 48(5):300060520926093. PubMed ID: 32468878
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
Giulino-Roth L; van Besien HJ; Dalton T; Totonchy JE; Rodina A; Taldone T; Bolaender A; Erdjument-Bromage H; Sadek J; Chadburn A; Barth MJ; Dela Cruz FS; Rainey A; Kung AL; Chiosis G; Cesarman E
Mol Cancer Ther; 2017 Sep; 16(9):1779-1790. PubMed ID: 28619753
[TBL] [Abstract][Full Text] [Related]
27. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma.
Qiao Q; Jiang Y; Li G
J Pharmacol Sci; 2013; 121(4):247-56. PubMed ID: 23603894
[TBL] [Abstract][Full Text] [Related]
30. Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells.
Bie B; Sun J; Li J; Guo Y; Jiang W; Huang C; Yang J; Li Z
Cell Physiol Biochem; 2017; 41(4):1519-1531. PubMed ID: 28351032
[TBL] [Abstract][Full Text] [Related]
31. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
[TBL] [Abstract][Full Text] [Related]
32. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
[TBL] [Abstract][Full Text] [Related]
33. Life and death decisions in B1 lymphoma cells.
Donjerković D; Carey GB; Mueller CM; Liu S; Scott DW
Curr Top Microbiol Immunol; 2000; 252():151-9. PubMed ID: 11187083
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.
Cho JH; Dimri M; Dimri GP
J Biol Chem; 2015 Apr; 290(16):10555-67. PubMed ID: 25737447
[TBL] [Abstract][Full Text] [Related]
35. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
Cui W; Zhang S; Shan C; Zhou L; Zhou Z
FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
[TBL] [Abstract][Full Text] [Related]
36. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
37. Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells.
Simões Magluta EP; Vasconcelos FC; Maia RC; Klumb CE
Cancer Invest; 2009 Oct; 27(8):830-5. PubMed ID: 19557576
[TBL] [Abstract][Full Text] [Related]
38. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
[TBL] [Abstract][Full Text] [Related]
39. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
[TBL] [Abstract][Full Text] [Related]
40. The role of microRNA-150 as a tumor suppressor in malignant lymphoma.
Watanabe A; Tagawa H; Yamashita J; Teshima K; Nara M; Iwamoto K; Kume M; Kameoka Y; Takahashi N; Nakagawa T; Shimizu N; Sawada K
Leukemia; 2011 Aug; 25(8):1324-34. PubMed ID: 21502955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
